Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Aureka Biotechnologies | 2026 | Series A | $23.4M | Laguna Hills |
| Collov Labs | 2026 | Series A | $8.0M | Redwood City |
| Lightelligence | 2025 | Series C | $210.4M | Boston |
| Smartpay | 2024 | Seed | $7.0M | Tokyo |
| Rgenta Therapeutics | 2023 | Series A | $8.0M | Cambridge |
| Aeroband | 2026 | Series A | $14.5M | Haidian |
| Galaxy Bot | 2026 | Series Unknown | $363.9M | Beijing |
| iSpace China | 2026 | Series D | $727.6M | Beijing |
| Adlai Nortye | 2026 | Post Ipo Equity | $140.0M | Hangzhou |
| Feijiecos | 2026 | Seed | $14.4M | Shanghai |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | Aureka Biotechnologies | Series A | $23.4M | Laguna Hills, United States |
| 2 | Collov Labs | Series A | $8.0M | Redwood City, United States |
| 3 | Lightelligence | Series C | $210.4M | Boston, United States |
| 4 | Smartpay | Seed | $7.0M | Tokyo, Japan |
| 5 | Rgenta Therapeutics | Series A | $8.0M | Cambridge, United States |
| 6 | Aeroband | Series A | $14.5M | Haidian, China |
| 7 | Galaxy Bot | Series Unknown | $363.9M | Beijing, China |
| 8 | iSpace China | Series D | $727.6M | Beijing, China |
| 9 | Adlai Nortye | Post Ipo Equity | $140.0M | Hangzhou, China |
| 10 | Feijiecos | Seed | $14.4M | Shanghai, China |
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.
Collov Labs is an Agentic Diffusion Lab— turning generative models into systems that can act, adapt, and scale across use cases.
Harnessing light to power new possibilities
Smartpay is a financial service company that helps consumers by offering standard paying, shopping, and consumer finance solutions.
Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology.
Aeroband is a manufacturer of air paddles and other musical instruments.
Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
iSpace designs and develops commercial space shuttle.
Adlai Nortye is a clinical-stage biopharmaceutical company that deveops cancer treatments for diverse tumor types.
Feijiecos is a smart technology supplier that specializes in smart technology and offers intelligent solutions.
PAQ Therapeutics is a biotechnology company pioneering a new approach to restoring health and curing disease through autophagy.
Gongye Technology makes use of AI and big data to manufacture intelligent equipment for solid waste sorting and recycling.
Alioth focuses on the development and application of technical products for pharmaceutical process technology.
INMO Glass are Foldable, monocular Augmented Reality (AR) glasses.
Weiyuan Synthetic Biotechnology specializes in the manufacturing of food, feed and materials based on synthetic biology technology.
Jiajin Biotech is a pharmaceutical R&D service provider.
Noitom Robotics is an intelligent robot development company specializing in the sales, installation, and maintenance of industrial robots.
KYinno is a drug development company that is dedicated to oncology drug development with a focus on immune treatments against cancer.
D3 Bio is a biotechnology company focusing on the development and registration of medicines.
iOranges Automation is an AI and robotics company.
Snapmaker is entirely made of metal, ensuring a high quality and reliable 3D printing experience.
Space Transportation designs and manufactures space transport systems intended to reduce space exploration costs.
Vastai Technologies is focused on developing AI chips for the optimization of computer vision and video processing.
GRIT Biotechnology develops tumor infiltration lymphocytes immunotherapy for solid tumors.
Neptune Robotics provides robotic hull cleaning, robotic hull inspection, and biofouling management services to maritime operators.
Matrix Partners China has invested in 280 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Matrix Partners China's top investment sectors include Biotechnology, Health Care, Manufacturing, Artificial Intelligence (AI), Pharmaceutical. The firm invests across 46 different industry categories.
Among tracked funding rounds, iSpace China received $727.6M in a Series D round. Matrix Partners China's total known invested capital is $6.3B.
Matrix Partners China's average investment size is $33.3M across its portfolio of 280 companies.
Recent Matrix Partners China portfolio additions include Aureka Biotechnologies, Collov Labs, Lightelligence, Smartpay, Rgenta Therapeutics. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors